EKEkin Kadioglu

Ekin Kadioglu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ekin Kadioglu has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • COVID-19 Pandemisinde Üçüncü Basamak Bir Hastane Deneyimi

    by Mine Filiz, Gülden Yılmaz, Gonca Fidan, Sümeyye Köşger, Ekin Kadıoğlu, Ümit Savaşçı, Yavuz Çekli, Nesrin Öcal, Deniz Doğan, Yakup Arslan, et al.


  • Open Access

    The boundaries between survival and nonsurvival at COVID‐19: Experience of tertiary care pandemic hospital

    by Yakup Arslan, Deniz Dogan, Nesrin Ocal, Alperen Koc, Tunahan Ayaz, Recep Ozkan, Fatma Yoruk, Meltem Nilsen Esmer, Sumeyye Kosger, Ekin Kadioglu, et al.

    Objective Coronavirus disease 2019 (COVID-19) is an emerging, fast-spreading, highly mortal and worldwide infectious disease. The pulmonary system was defined as the main target of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the mortality concept of this disease presented with more severe and systemic disease. The present study investigated the relationship between the patient characteristics at the initial hospital administration and fatality in COVID-19 patients. Methods In this retrospective and comparative cohort study, all the 767 hospitalised COVID-19 patients, treated between 18 March and 15 May 2020 in the Covid Clinics of Gulhane Training and Research Hospital in Ankara, Turkey, were evaluated. Results The fatality rate was significantly increased in patients with any comorbid disease except asthma. The initial laboratory test results indicated highly significant differences according to the patient's outcome. A multifactor logistic regression analysis was performed to calculate the adjusted odds ratios for predicting patient outcomes. Being older than 60 years increased the death risk with an adjusted OR of 7.2 (95% CI: 2.23-23.51; P = .001). The presence of a cancer and the extended duration of intensive care unit treatment were other significant risk factors for nonsurvival. Azithromycin treatment was determined as significantly reduced the death ratio in these patients (P = .002). Conclusion It was revealed that being older than 60 years, presence of a cancer and extended duration of ICU treatment were the major risk factors for predicting fatality rate in hospitalised COVID-19 patients.